The prospectus is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any other jurisdiction in which such release, publication or distribution would be unlawful.
Neither the delivery of the prospectus nor the issue, sale or
delivery of any note shall, in any circumstances, create any
implication that the information contained in the prospectus is true
subsequent to the date thereof or, if the prospectus is supplemented
after the date thereof, the date of the relevant supplement or that
there has been no adverse change, or any event reasonably likely to
involve any adverse change, in the prospects or financial or trading
position of Novo Nordisk A/S since the date thereof or, if the
prospectus is supplemented after the date thereof, the date of the
relevant supplement or that any other information supplied in
connection with the notes is correct at any time subsequent to the
date on which it is supplied or, if different, the date indicated in
the document containing the same.
The prospectus is not intended to provide the basis of any credit or
any other evaluation and should not be considered as a recommendation
by Novo Nordisk A/S that any recipient of the prospectus should invest
in the notes. Prospective investors should make an independent
assessment as to whether the information in the prospectus is relevant
to their situation, and any investment in the notes should be based on
the information regarding the investor's specific circumstances that
the investor may deem necessary and only if the notes are consistent
with the investor’s financial objectives.
The distribution of the prospectus and the offering or sale of notes
in certain jurisdictions may be restricted by law. The prospectus may
not be distributed or otherwise made available and the notes may not
be offered or sold, directly or indirectly, in any jurisdiction,
unless such distribution, offering or sale is permitted under
applicable laws in the relevant jurisdiction.
The notes have not been and will not be registered under the United
States Securities Act of 1933, as amended (the "Securities
Act") and may not be offered or sold within the United States or
to, or for the account or benefit of, U.S. persons except in certain
transactions exempt from the registration requirements of the
References above to the “prospectus” are to the prospectus as
supplemented from time to time.